Kontratar

Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

SAM
N/A
Award Notice

Posted

Sep 25, 2026

Location

Jersey City, New Jersey

Description

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=5d2b1c5f6d094d72ad9916f20fc33ed3

Details

Notice ID
5d2b1c5f6d094d72ad9916f20fc33ed3
Solicitation Number
BAA-23-100-SOL-00004
NAICS Code
N/A
Classification Code
N/A

Want to track opportunities like this?

Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.

Get Started Free

Browse all federal contract opportunities